Patents by Inventor Thomas Ransohoff

Thomas Ransohoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioreactor Systems and Methods of Operating Same
    Publication number: 20260176561
    Abstract: The systems and methods disclosed herein can generate product from cells using a bioreactor system. The bioreactor system can include a centrifuge. The bioreactor system can use a centrifuge to improve product yield. The centrifuge can be used to separate content received from the bioreactor. The separated content can be diverted back to the bioreactor, or filtered and/or collected.
    Type: Application
    Filed: October 25, 2023
    Publication date: June 25, 2026
    Inventors: Huanchun Cui, Thomas Erdenberger, Thomas Ransohoff
  • Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof
    Patent number: 12390509
    Abstract: Pharmaceutical compositions comprising a TAT-FXN fusion polypeptide are disclosed, as are methods of use of the pharmaceutical compositions to treat subjects diagnosed with Friedrich's Ataxia and/or hypertrophic cardiomyopathy.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: August 19, 2025
    Assignee: Larimar Therapeutics, Inc.
    Inventors: Denis Boyle, Thomas Ransohoff
  • PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF
    Publication number: 20220193190
    Abstract: Pharmaceutical compositions comprising a TAT-FXN fusion polypeptide are disclosed, as are methods of use of the pharmaceutical compositions to treat subjects diagnosed with Friedrich's Ataxia and/or hypertrophic cardiomyopathy.
    Type: Application
    Filed: December 13, 2021
    Publication date: June 23, 2022
    Inventors: Denis Boyle, Thomas Ransohoff